219 related articles for article (PubMed ID: 34139238)
1. A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain.
Light TP; Gomez-Soler M; Wang Z; Karl K; Zapata-Mercado E; Gehring MP; Lechtenberg BC; Pogorelov TV; Hristova K; Pasquale EB
J Biol Chem; 2021 Jul; 297(1):100876. PubMed ID: 34139238
[TBL] [Abstract][Full Text] [Related]
2. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
[TBL] [Abstract][Full Text] [Related]
3. Identification of the genomic mutation in Epha4(rb-2J/rb-2J) mice.
Mohd-Zin SW; Abdullah NL; Abdullah A; Greene ND; Cheah PS; Ling KH; Yusof H; Marwan AI; Williams SM; York KT; Ahmad-Annuar A; Abdul-Aziz NM
Genome; 2016 Jul; 59(7):439-48. PubMed ID: 27373307
[TBL] [Abstract][Full Text] [Related]
4. Ectopic EphA4 receptor induces posterior protrusions via FGF signaling in Xenopus embryos.
Park EK; Warner N; Bong YS; Stapleton D; Maeda R; Pawson T; Daar IO
Mol Biol Cell; 2004 Apr; 15(4):1647-55. PubMed ID: 14742708
[TBL] [Abstract][Full Text] [Related]
5. Development and structural analysis of a nanomolar cyclic peptide antagonist for the EphA4 receptor.
Lamberto I; Lechtenberg BC; Olson EJ; Mace PD; Dawson PE; Riedl SJ; Pasquale EB
ACS Chem Biol; 2014 Dec; 9(12):2787-95. PubMed ID: 25268696
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Jak/Stat proteins as novel downstream targets of EphA4 signaling in muscle: implications in the regulation of acetylcholinesterase expression.
Lai KO; Chen Y; Po HM; Lok KC; Gong K; Ip NY
J Biol Chem; 2004 Apr; 279(14):13383-92. PubMed ID: 14729671
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor.
Qin H; Shi J; Noberini R; Pasquale EB; Song J
J Biol Chem; 2008 Oct; 283(43):29473-84. PubMed ID: 18708347
[TBL] [Abstract][Full Text] [Related]
8. Structural characterization of the EphA4-Ephrin-B2 complex reveals new features enabling Eph-ephrin binding promiscuity.
Qin H; Noberini R; Huan X; Shi J; Pasquale EB; Song J
J Biol Chem; 2010 Jan; 285(1):644-54. PubMed ID: 19875447
[TBL] [Abstract][Full Text] [Related]
9. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.
Bhatia S; Hirsch K; Baig NA; Rodriguez O; Timofeeva O; Kavanagh K; Lee YC; Wang XJ; Albanese C; Karam SD
J Hematol Oncol; 2015 Sep; 8():105. PubMed ID: 26345456
[TBL] [Abstract][Full Text] [Related]
10. Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling.
Bowden TA; Aricescu AR; Nettleship JE; Siebold C; Rahman-Huq N; Owens RJ; Stuart DI; Jones EY
Structure; 2009 Oct; 17(10):1386-97. PubMed ID: 19836338
[TBL] [Abstract][Full Text] [Related]
11. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor.
Lamberto I; Qin H; Noberini R; Premkumar L; Bourgin C; Riedl SJ; Song J; Pasquale EB
Biochem J; 2012 Jul; 445(1):47-56. PubMed ID: 22489865
[TBL] [Abstract][Full Text] [Related]
12. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
13. EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line.
Fukai J; Yokote H; Yamanaka R; Arao T; Nishio K; Itakura T
Mol Cancer Ther; 2008 Sep; 7(9):2768-78. PubMed ID: 18790757
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of EphA4, growth hormone receptor, Janus kinase 2, and signal transducer and activator of transcription 5B.
Sawada T; Arai D; Jing X; Miyajima M; Frank SJ; Sakaguchi K
PLoS One; 2017; 12(7):e0180785. PubMed ID: 28686668
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the ligand-binding domain of the promiscuous EphA4 receptor reveals two distinct conformations.
Singla N; Goldgur Y; Xu K; Paavilainen S; Nikolov DB; Himanen JP
Biochem Biophys Res Commun; 2010 Sep; 399(4):555-9. PubMed ID: 20678482
[TBL] [Abstract][Full Text] [Related]
16. Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.
Saintigny P; Peng S; Zhang L; Sen B; Wistuba II; Lippman SM; Girard L; Minna JD; Heymach JV; Johnson FM
Mol Cancer Ther; 2012 Sep; 11(9):2021-32. PubMed ID: 22807579
[TBL] [Abstract][Full Text] [Related]
17. AKT-dependent phosphorylation of the SAM domain induces oligomerization and activation of the scaffold protein CNK1.
Fischer A; Weber W; Warscheid B; Radziwill G
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):89-100. PubMed ID: 27769899
[TBL] [Abstract][Full Text] [Related]
18. Regulation of axonal EphA4 forward signaling is involved in the effect of EphA3 on chicken retinal ganglion cell axon growth during retinotectal mapping.
Fiore L; Medori M; Spelzini G; Carreño CO; Carri NG; Sanchez V; Scicolone G
Exp Eye Res; 2019 Jan; 178():46-60. PubMed ID: 30237102
[TBL] [Abstract][Full Text] [Related]
19. Trans-activation of EphA4 and FGF receptors mediated by direct interactions between their cytoplasmic domains.
Yokote H; Fujita K; Jing X; Sawada T; Liang S; Yao L; Yan X; Zhang Y; Schlessinger J; Sakaguchi K
Proc Natl Acad Sci U S A; 2005 Dec; 102(52):18866-71. PubMed ID: 16365308
[TBL] [Abstract][Full Text] [Related]
20. A role of the SAM domain in EphA2 receptor activation.
Shi X; Hapiak V; Zheng J; Muller-Greven J; Bowman D; Lingerak R; Buck M; Wang BC; Smith AW
Sci Rep; 2017 Mar; 7():45084. PubMed ID: 28338017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
